Categories: Uncategorized

DXC Technology Names Brad Novak as Chief Information Officer

Veteran Technology Executive Joins DXC’s Leadership Team

ASHBURN, Va., Jan. 2, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Brad Novak as Chief Information Officer. Novak joins DXC’s leadership team, with a strong focus on leveraging AI throughout DXC operations. He will report to DXC’s Chief Administrative Officer, James Walker.

In this role, Novak will strategically embed AI across the infrastructure. He will also lead the team to integrate, standardize and consolidate various platforms, tools, and processes to enhance workforce productivity and operational efficiency. 

Novak is a senior technologist and brings over 30 years of experience in financial services, spanning application development, infrastructure and service management. He has worked at several global financial services firms, most recently Barclays, where he was the CTO for the Corporate and Investment Bank, leading technology architecture and strategy. Novak has also worked in Private Equity and Venture Capital, assessing investment opportunities and advising portfolio companies on their technology strategies.   

- Advertisement -

For more information DXC’s leadership team, visit here.

Forward Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that any result, goal or plan set forth in any forward-looking statement can or will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. For a written description of these factors, see the section titled “Risk Factors” in DXC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and any updating information in subsequent SEC filings. Readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission-critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services to drive new levels of performance, competitiveness, and customer experience across their IT estates. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.

- Advertisement -

CONTACT: Mihir Bellamkonda, Media Relations, mihir.bellamkonda@dxc.com; Roger Sachs, Investor Relations, roger.sachs@dxc.com

Photo – https://mma.prnewswire.com/media/2589628/DXC_Technology_Company_DXC_Technology_Names_Brad_Novak_as_Chief.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dxc-technology-names-brad-novak-as-chief-information-officer-302341382.html

- Advertisement -
adkhabarmda

Recent Posts

Chery Debuts All-New HIMLA Series at 2025 Shanghai Auto Show, Redefining the Pickup Market with Full-Category Lineup

SHANGHAI, April 26, 2025 /PRNewswire/ -- On April 23, under the spotlight at 2025 Shanghai…

9 hours ago

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

April 26, 2025 10:00 ET  | Source: Protara Therapeutics TARA-002 demonstrates 100% complete response rate…

11 hours ago

RAD-140 SARMs Rad 140 Testolone Benefits, Dosage, Safety, and Where to Buy Sarms Online (by Crazy Bulk USA)

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- The fitness and bodybuilding industry is constantly…

11 hours ago

Prime Biome (Ive Tested It for 90 Days) Heres My Honest Prime Biome Gummies Review And Shocking Results! (Good, Bad & Real)

LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a rigorously developed herbal…

11 hours ago

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV…

11 hours ago

Burnjaro Under Review: Analyzing the Results of Burn Jaro Slimming Ingredients to Instantly Burn Belly Fat

Norcross, Georgia, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why belly…

11 hours ago